1. From the Department of Gynecologic Oncology, Norwegian Radium Hospital, and Department of Clinical Pharmacology, National Hospital, Oslo, Norway; Department of Gynecologic Oncology, St Stephen Hospital, Budapest, Hungary; Department of Medical Oncology, Odense University Hospital, Odense, Denmark; and Novartis Pharmaceuticals, Basel, Switzerland.